| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Revenue | $28.50B | +2.6% |
| R&D Expense | $2.04B | +3.3% |
| SG&A Expense | $4.94B | +0.2% |
| Operating Income | $782.0M | -30.9% |
| Interest Expense | $471.0M | -6.0% |
| Pre-tax Income | $876.0M | -75.6% |
| Income Tax | $8.0M | -95.0% |
| Net Income | $868.0M | -74.7% |
| EPS (Basic) | $0.67 |
| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.16B | +4.2% |
| Accounts Receivable | $4.10B | +3.1% |
| Inventory | $5.16B | +14.4% |
| Current Assets | $20.51B | +8.6% |
| Total Assets | $57.12B | -1.0% |
| Current Liabilities | $23.17B | +12.0% |
| Long-term Debt | $11.94B | -4.1% |
| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.59B | -21.8% |
| Investing Cash Flow | -$2.09B | +25.4% |
| Financing Cash Flow | -$1.80B | +46.6% |
| -74.4% |
| EPS (Diluted) | $0.66 | -74.4% |
| Stockholders' Equity |
| $19.86B |
| -0.5% |